Switzerland· 56880003
Emtriva
A emtricitabine product containing emtricitabinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AF09 (emtricitabine), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Emtricitabine · ATC J05AF09
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of emtricitabine costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- Switzerland: $8.60 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Emtricitabine · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$8.60
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- emtricitabinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AF09
- ATC class
- Emtricitabine
- Defined daily dose
- 0.2 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768056880003330 StkCHF 213.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
32 interactions on record for emtricitabine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine · interactions on record
32 records
- 4 severe
- 23 moderate
- 1 minor
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Emtricitabine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesemtricitabineCipla USA Inc.
- CzechiaEMTRIVAGilead Sciences Ireland UC, Carrigtohill
- FinlandEmtrivaOrifarm Oy
- United KingdomEmtriva 200mg capsulesGilead Sciences Ltd
- BelgiumEmtriva 200 mgGilead Sciences Ireland UC
- IcelandEmtrivaGilead Sciences Ireland UC*
- NetherlandsEmtriva 200 mg, harde capsulesGilead Sciences Ireland UC
- NorwayEmtrivaGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Emtricitabina/Tenofovir Alafenamida Dr. Reddys
- Iceland · Emtriva
- Liechtenstein · Emtriva
- Norway · Emtriva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/182bd885-a0e9-4773-b72a-5d3827a8ed4f GET /v1/drugs/182bd885-a0e9-4773-b72a-5d3827a8ed4f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "emtricitabinum 200 mg",
"valid_from": "2004-12-01",
"limitations": null,
"galenic_form": "Kaps 200 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2004-12-01",
"self_retention_pct": 10
}See everything about emtricitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.